About Javeri
Product & Services
Equity
Derivatives
Mutual Funds
IPO
Corporate Info
Research
Contact Us
Corporate Info
Smart Quotes
Company Background
Board of Directors
Balance Sheet
Profit & Loss
Peer Comparison
Cash Flow
Shareholdings Pattern
Quarterly Results
Share Price
Deliverable Volume
Historical Volume
MF Holdings
Financial Ratios
Directors Report
Price Charts
Notes Of Account
Management Discussion
Beta Analysis
Board Meetings
Corporate Announcements
Book Closure
Record Date
Bonus
Company News
Bulk Deals
Block Deals
Monthly High/low
Dividend Details
Bulk Deals
Insider Trading
Advanced Chart
HOME
>
CORPORATE INFO
>
PEER COMPARISON
Peer
Comparison
Astrazeneca Pharma India Ltd.
Peer Companies
Price(Rs)
Chg(Rs)
Chg(%)
EPS(Rs.)
TTM P/E
Volume(000's)
1Year Return(%)
Divinded Yield
Book Value
Sanofi Cons. Health
4586.85
124.85
2.8
94.61
48.48
316
-6.15
1.2
118.26
Procter&Gamble Healt
5684.25
51.35
0.91
184.83
30.75
72
4.37
2.19
320.52
Haleos Labs
1268.95
44.8
3.66
62.97
20.15
2
5.57
0.12
652.19
Everest Organics
502.5
44.25
9.66
6.81
73.79
6315
70.19
0
71
Abbott India
28914.05
42.35
0.15
710.12
40.72
248
0.98
1.65
1978.48
Kwality Pharma
1136.3
34.85
3.16
47.31
24.02
15291
29.44
0
255.44
Onesource Specialty
1764.6
22.65
1.3
14.29
123.46
13973
0
516.29
FDC
422.2
14.75
3.62
14.52
29.09
4237
-16.16
1.18
140.48
Senores Pharmaceutic
827.1
13.3
1.63
2.65
311.96
6952
0
153.74
Glaxosmithkline Phar
2476.65
11.75
0.48
55.99
44.24
3433
10.48
2.18
115.94
Jenburkt Pharma
1083.6
8.9
0.83
74.77
14.49
452
-9.78
1.65
389.23
NGL Fine-Chem
1299.5
8.05
0.62
25.58
50.8
81
-29.19
0.13
452.6
Gufic Biosciences
339.85
6
1.8
5.42
62.76
2437
-24.73
0.03
59.96
Ajanta Pharma
2686.75
5.95
0.22
76.07
35.32
1585
-3.89
1.04
289.84
Guj. Themis Biosyn
448.95
4.55
1.02
4.43
101.29
17514
45.93
0.15
22.79
Trident Lifeline
284.95
4.1
1.46
10.94
26.05
12600
4.38
0
57.14
Ishita Drugs & Inds.
80
4
5.26
3.25
24.64
1065
-13.51
0
36.08
Sanjivani Paranteral
230.05
3.65
1.61
6.07
37.9
6108
-38.33
0.22
30.84
Smruthi Organics
121.9
3.35
2.83
4.08
29.85
8308
3.09
1.23
62.58
Indoco Remedies
229.8
3.25
1.43
-5.36
0
275
-30.89
0.09
118.99
Page
1
of
10
Prev
||
Next
Disclaimer
|
Privacy Policy
| Grievance |
FAQ
|
Sitemap |
Client Registration |
Useful Links
|
Anti Money Laundering
|
Inactive Client Policy
|
Scores
Smart ODR Portal
|
Vernacular Kyc
|
Advisory For Investors
|
Investor Adviser
|
Filing complaints on SCORES - Easy & quick
|
Policy on PMLA
|
Publishing of investor charter information
|
Annexure A – Investor charter of brokers
|
Annexure A – Investor charter of DP
|
Annexure B –Linked content for information to charter for DP
|
Annexure B & C (investor complaint data) broker & DP
|
Investor Charter & Complaints
|
Advisory-KYC Compliance
|
E-Voting NSE
|
E-Voting BSE
|
Details of Client Bank Accounts
|
Risk Disclosure
|
NSE FO Risk disclosure
|
Details of Research Analyst
|
UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by
Accord Fintech Pvt. Ltd.
CLOSE
X
RISK DISCLOSURES ON DERIVATIVES
9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source:
Click Here.